Position in JAZZ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$39,282,447
+$8,175,782 QoQ
Shares Held
163,018
-0.9% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#58
of 629 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,298,250 across 329 Biotechnology names. JAZZ ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
163,018 | $39,282,447 |
All Filings in JAZZ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,282,447 | 163,018 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $31,106,665 | 164,542 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $26,899,780 | 158,234 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $21,702,319 | 164,661 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $17,511,073 | 165,012 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $20,429,627 | 164,556 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $20,635,014 | 167,560 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $18,472,335 | 165,805 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $18,080,062 | 169,400 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $22,277,338 | 184,997 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $22,850,940 | 185,780 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $24,333,296 | 187,989 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $23,512,770 | 189,665 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $26,701,566 | 182,475 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $28,839,411 | 181,027 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $24,079,771 | 180,657 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $27,559,322 | 176,651 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $25,247,494 | 162,186 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $20,755,371 | 162,915 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $19,964,318 | 153,324 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $27,964,977 | 157,425 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $24,628,378 | 149,835 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $24,872,209 | 150,695 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $22,909,222 | 160,665 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,299,885 | 75,221 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,246,908 | 72,658 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||